A Prospective Cohort Study of Patients Suffering From Hand Osteoarthritis Symptoms (COARDIG)

September 24, 2025 updated by: University Hospital, Montpellier

A Prospective Cohort Study of Patients Suffering From Hand Osteoarthritis

The late-stage forms of degenerative osteoarthritis (OA) are very debilitating and less affordable to therapy. The main objective is to identify early onset symptoms of hand OA patients through imaging techniques (such as ultrasound and MRI). Our primary endpoint is to specify patients with high risk of radiological profression (X-ray).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Montpellier, France, 34295
        • Recruiting
        • Department of Rheumatology, CHU Montpellier
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

- Early digital osteoarthritis must combine the clinical AND radiological definition.

Clinical definition:

At least one of the following 4 criteria: Pain or stiffness or swelling or deformity of a digital joint (IPP and / or IPD) A breach of at least one PPI and / or IPD Age under 60 at the time of the first symptoms Clinical symptoms have been changing for less than 3 years

Radiographic definition:

The presence of the achievement of at least one PPI and / or IPD. Presence of at least two of the following three criteria: pinching, marginal subchondral condensation, marginal osteophyte Erosion on radiography is not an exclusion criteria

- Consent form signed

Exclusion criteria:

  • patients suffering from rheumatoid arthritis, rheumatoid psoriasis or any other inflammatory rheumatism
  • patients suffering from metabolic diseasis such as gout, hemochromatosis, Wilson's disease; or from congenital disease such as displasie, osteogenesis,
  • Presence of advanced radiographic osteoarthritis based in Kellgreen Lawrence score (=4) in one joint among the 10 previous sites.
  • Not able to provide a sample of blood for any reasons
  • MRI contraindication
  • Being in exclusion period determined by another previous study
  • Subject non affiliated to social insurance
  • Pregnant or lactating women
  • Vulnerable people based in L1121-5 article of CSP
  • Elderly subject or protected subjects disabled to give their consent
  • Subjects private of freedom by court or administrative order

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Diagnostic Test: Identification of subgroups of patients with
Clinical examination with questionnaires, Biological collection, Imaging (radiography, densitometry, ultrasound, and MRI)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiographic progression judged by the number of joints whose KL index has evolved
Time Frame: 2 years
Evaluation of prognostic role of imaging factors in x-ray progression of early onset hand osteoarthritis
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of painful / swollen or deformed joints in the hands.
Time Frame: 2 years
Photographs of the patients' hands will be taken at each visit.
2 years
The location of painful / swollen or deformed joints in the hands.
Time Frame: 2 years
Photographs of the patients' hands will be taken at each visit.
2 years
The intensity of pain over the last 48 hours
Time Frame: 2 years
The intensity of pain over the last 48 hours will be assessed by the patient at each visit on a visual analogue scale (VAS). EVA pain (visual analogue scale over 100 mm): one-dimensional measurement of the intensity of pain. EVA pain is a continuous scale consisting of a horizontal line from 0 (no pain) to 100 mm (maximum pain)
2 years
The activity of the disease over the last 48 hours
Time Frame: 2 years
The activity of the disease over the last 48 hours will be evaluated at each visit by the patient and the doctor on a visual analog scale from 0 (no pain) to 100 mm (maximum pain)
2 years
The aesthetic impact of osteoarthritis of the hands
Time Frame: 2 years
The aesthetic impact of osteoarthritis of the hands will be evaluated at each visit by the patient on a visual analog scale from 0 (no pain) to 100 mm (maximum pain)
2 years
The number of consumption of care in the month preceding the visit
Time Frame: 2 years
2 years
The number of hand surgery during follow-up 56/5000 The number of a hand surgery during follow-up
Time Frame: 2 years
2 years
The grip force measured by a dynamometer
Time Frame: 2 years
2 years
The impact on pain and function on the hand measured by the AUSCAN questionnaire
Time Frame: 2 years
The impact on pain and function measured by the AUSCAN questionnaire. This is a functional index including 15 questions with a specific orientation to osteoarthritis of the hands, assessing pain / stiffness and function. The score varies from 0 to 60. Fill in the questionnaire: 7 min
2 years
The impact on pain and function on the hand measured by the COCHIN functional index
Time Frame: 2 years
The impact on pain and function measured by the COCHIN functional index wich is oriented towards AD. It includes 18 questions, ranging from 0 to 5, and is particularly interested in the impact of osteoarthritis of the hands on the daily activities (cooking, clothing, hygiene, office ...) of the patient. The score varies from 0 to 90. Questionnaire filling time: 5 min
2 years
The impact on pain and function on the hand measured by a 6-minute walk test
Time Frame: 2 years
The impact on pain and function measured by a 6-minute walk test that characterizes an overall assessment of functional ability to exercise. The patient is asked to walk as much as possible for 6 minutes (round trip in a 30m corridor), the pace of walking is freely chosen (ATS Recommendations, 2002)
2 years
The impact on pain and function measured the IPAQ International Physical Activity Questionnaire
Time Frame: 2 years
The short version with 7 questions will be used
2 years
The professional impact measured by the WPAI questionnaire which measures the deficiencies of paid work and unpaid work over the last 7 days
Time Frame: 2 years
The WPAI questionnaire is an instrument for measuring deficiencies in paid work and unpaid work over the last 7 days. It measures absenteeism, presenteeism as well as the deficiencies of unpaid activity due to a health problem. It contains 6 questions and has already been used during AD
2 years
Impact on quality of life measured by the Health Assessment Questionnaire (HAQ)
Time Frame: 2 years
The Health Assessment Questionnaire (HAQ) is a measure of quality of life in health. The questionnaire is designed to be completed by the patient himself, without the help of a doctor. We will use an adaptation of the HAQ, the Modified Health Assessment Questionnaire (MHAQ), as in the Kwok et al. Study, with 8 questions about the function of the hand. The score ranges from 0 to 3. The average score reported in osteoarthritis studies is 0.8. It is 0.49 in the global population.
2 years
The impact on the quality of life measured by the SF-36 questionnaire
Time Frame: 2 years
The SF-36 questionnaire assesses the quality of life. It is a validated international questionnaire. It consists of 36 items evaluating 8 dimensions. It can be used in health economics studies as a variable in the calculation of a Quality Adjusted Life Year (QALY) to determine the cost-effectiveness of a health intervention. Fill in the questionnaire: 10 min.
2 years
The impact on the quality of life measured by the EQ-5D-3L questionnaire (https://euroqol.org)
Time Frame: 2 years
This score varies between 0 and 1: 0 represents death, and 1 the best quality of life possible. So, this score indicates the decrease in quality of life compared to an optimal state of health. The more desirable a health state, the higher the score associated with it. Negative scores are possible if the subject perceives a state of health worse than death. The EQ-5D-3L includes the following five dimensions: mobility, self-care, usual activities, pain / discomfort, and anxiety / depression. Each dimension has 3 levels: absence of problems, presence of problems and extreme problems. Questionnaire filling time: 5 min
2 years
The Impact on Quality of Life Measured by the Michigan Hand Outcome Questionnaire (MHQ)
Time Frame: 2 years
It is an international questionnaire validated with 6 items, which assesses the aesthetic impact of osteoarthritis of the hands. The questionnaire includes the function of the overall hand, the activities of daily life, the pain, the work, the appearance of the hands and the satisfaction of the patient with the functionality of his hands. In the ladder pain, a high score indicates more intense pain, while in the rest of the items, a better score reveals better hand functionality. Duplicate filling time: 15 min.
2 years
The psychological impact of pain measured by the HAD questionnaire (Hospital Anxiety and Depression)
Time Frame: 2 years
This questionnaire assesses the psychological impact of the patient. It consists of 14 questions with 4 possible answers. This score makes it possible to differentiate a level of anxiety and a level of depression according to the answers. Each sub-scale varies from 0 to 21. Questionnaire filling time: 5 min
2 years
The aesthetic impact of osteoarthritis of the hands with the Michigan Hand Outcome Questionnaire
Time Frame: 2 years
The aesthetic impact of osteoarthritis of the hands will be evaluated at each visit by the patient with the help of the Michigan Hand Outcome Questionnaire. It is an international questionnaire validated with 6 items, which assesses the aesthetic impact of osteoarthritis of the hands. The questionnaire includes the function of the overall hand, the activities of daily life, the pain, the work, the appearance of the hands and the satisfaction of the patient with the functionality of his hands. In the ladder pain, a high score indicates more intense pain, while in the rest of the items, a better score reveals better hand functionality. Duplicate filling time: 15 min (MHQ)
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yves-Marie PERS, MD, University Hospital, Montpellier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2019

Primary Completion (Estimated)

July 31, 2028

Study Completion (Estimated)

October 31, 2028

Study Registration Dates

First Submitted

August 22, 2018

First Submitted That Met QC Criteria

August 24, 2018

First Posted (Actual)

August 29, 2018

Study Record Updates

Last Update Posted (Estimated)

September 30, 2025

Last Update Submitted That Met QC Criteria

September 24, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • RECHMPL17_0391
  • 2017-A03378-45 (Registry Identifier: ID-RCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hand Osteoarthritis

Clinical Trials on Identification of subgroups of patients with early AD with risk of progression

Subscribe